DEA Announces All Illicit Fentanyl Analogues Will Be Subject to Criminal...
The announcement comes from the Department of Justice and will give the Drug Enforcement Agency the ability to take immediate action to stop illicit fentanyl from coming into the US.
View ArticleClinton Foundation's Recommendations to Address the Opioid Crisis
The Clinton Foundation's Health Matters Initiative, in partnership with the Johns Hopkins Bloomberg School of Public Health, issued a report providing 49 recommendations under 10 topic areas on how to...
View ArticlePregabalin Monotherapy Superior to Opioids With or Without Pregabalin in...
The use of pregabalin alone vs pregabalin plus opioids or opioids alone may result in more favorable outcomes in terms of pain interference and pain severity in patients with fibromyalgia.
View ArticleShort- vs Long-Acting Opioids for Osteoarthritis Pain
In addition to being safer and more cost-effective, short-acting opioids are comparable with long-acting opioids for pain management in patients with chronic osteoarthritis.
View ArticleFDA Grants Priority Review to Lofexidine for Management of Opioid Withdrawal...
US WorldMeds announced that the Food and Drug Administration has accepted for Priority Review the New Drug Application for lofexidine to manage the symptoms associated with opioid withdrawal and to...
View ArticleImmediate Access to Opioid Agonist Treatment Is Cost-Effective, Beneficial
Immediate access to opioid agonist treatment for patients presenting with opioid use disorder may provide greater health benefits at less cost than observed standard of care.
View ArticleJoint Commission Provides Insights Into Current Opioid Prescribing Trends,...
The Joint Commission has provided insight into trends in opioid prescriptions over the last 3 decades, as well as current quality and safety problems in acute pain management.
View ArticleChronic Pain Management Malpractice Claims: Insight Into Underlying Causes
Malpractice claims in outpatient chronic pain management most commonly involved patient noncooperation in care and provider deficits in clinical judgment, communication, and documentation.
View ArticleHigh Risk of Prescription Opioid, Heroin Overdose in Baby Boomer Generation
Individuals born between 1947 and 1964 have a significantly increased risk of prescription opioid overdose death and heroin overdose death, and those born from 1979 to 1992 also have an increased risk...
View ArticleChronic Pain Management in Primary Care Settings
From helping patients with opioid addiction to finding pain management programs, one physician shares his experience with chronic pain management in the primary care setting.
View ArticleHigh Risk for Prescription Opioid, Heroin Overdose in Baby Boomer Generation
Individuals born between 1947 and 1964 have a significantly increased risk for prescription opioid overdose death and heroin overdose death, and those born from 1979 to 1992 also have an increased risk...
View ArticlePostoperative Pain Management in Children With Developmental Delay
Parent- and nurse-controlled analgesia may not reduce postoperative pain in children with developmental delay compared with opioids administered by a nurse as needed.
View ArticleThe Opioid Crisis and the Increase in Hepatitis C Virus Infections
The prevalence of opioid abuse has not only resulted in a substantial increase in drug-related deaths and HIV transmissions, but has also led to an increase in the number of people infected with HCV.
View ArticleOpioid Prescribing vs Consumption Following Rhinoplasty
Patients used only 40% of the hydrocodone-acetaminophen combination tablets prescribed to them following rhinoplasty.
View ArticleOpioid Epidemic Response May Restrict Cancer-Related Pain Management
Although much of the response to the opioid epidemic exempts treatment for cancer-related pain, a recent Oncology Nurse Advisor online survey showed that more than 80% of respondents were concerned...
View ArticleBest Practices for Discussing Opioid Tapering With Your Patients
Helping patients understand individualized reasons for opioid tapering and encouraging them to provide input into the process are key for patient-provider communications.
View ArticleOb-Gyns Opioid Prescribing Practices Need Improvement
Improvement in obstetrician-gynecologists' knowledge and prescribing practices regarding opioids is needed.
View ArticleStatins Ineffective in Reducing Pain, Opioid Consumption After Hip Surgery
The use of statins after hip surgery may not reduce pain levels or the need for opioids.
View ArticleTopical Analgesics Aid Opioid Discontinuation, Pain Management
In a recent study, about half of the study patients taking opioids who were prescribed topical analgesics for pain management discontinued their opioids after 3 to 6 months of treatment.
View ArticleFDA Tentatively Approves Arymo ER Label Update for Abuse-Deterrent Claims
The FDA has tentatively approved an update to the Arymo ER extended-release tablets labeling to include data from an intranasal abuse-deterrent claim.
View Article
